您好，欢迎来到试剂仪器网！ [登录] [免费注册]
试剂仪器网
发布求购
位置：首页 > 产品库 > CVN424
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
CVN424
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
CVN424图片
CAS NO:2254706-21-1
包装与价格：
包装价格(元)
5mg电议
10mg电议
25mg电议

产品介绍
CVN424 是一种具有口服活性和选择性的 GPR6 反向激动剂，EC50 为 9.4 nM，EC50 为 38 nM。CVN424 可以透过血脑屏障，具有用于帕金森病研究的潜力。
Cas No.2254706-21-1
分子式C24H29F2N5O3
分子量473.52
溶解度DMSO : 62.5 mg/mL (131.99 mM; Need ultrasonic)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

CVN424 is an orally active and selective GPR6 inverse agonist with a EC50 of 9.4 nM and an EC50 of 38 nM. CVN424 is brain-penetrant and has the potential for Parkinson disease research[1][2].

CVN424 (Compound 6i) has 265 fold and 68 fold selectivities over GPR3 and GPR12[1].

[1]. Huikai Sun, et al. First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate. J Med Chem. 2021 Apr 16.
[2]. Nicola L Brice, et al. Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease. J Pharmacol Exp Ther. 2021 Jun;377(3):407-416.